Evaluate Appropriate Use of Opioid and Benzodiazepine Combos
You’ll see an even bigger push to avoid opioid and benzodiazepine combos in older patients...due to a new Star Rating quality measure for Medicare plans.
You’re well aware of opioid and benzo combo dangers, such as increased risks of respiratory depression and death...and Beers Criteria concerns of cognitive impairment and falls in older people.
Starting in 2027, CMS will track opioid and benzodiazepine combos as a quality measure for Medicare Part D and Advantage plans. But this matters NOW...since ratings are based on data from 2 years prior.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote